| GlaxoSmithKline AG - Jemperli 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 68023 | | 01 | | Jemperli 500 mg/10 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FF07 | | | | 17.02.2022 | | |
|
| Composition |
| dostarlimabum 500 mg, natrii citras dihydricus, acidum citricum monohydricum, arginini hydrochloridum, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 22.78 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Dostarlimabum | 500mg / 10ml |
| | BAG: Active Agent | Dose |
|---|
| Dostarlimabum | 500 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Arginine Hydrochloride | | Sodium Chloride | | Natrii Citras Dihydricus | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 5106.58 | 5485.60 | A | SL | Yes |
|
